|
TSLA
|
Consumer Cyclical |
UBS |
Maintains
|
Buy
→
Buy
|
—
|
$1.4T
|
$233.07
|
-1.0%
|
-0.6%
|
+5.5%
|
+2.5%
|
-6.5%
|
-0.5%
|
|
V
|
Financial Services |
Piper Sandler |
Maintains
|
Overweight
→
Overweight
|
—
|
$648.6B
|
$200.54
|
-0.3%
|
+0.3%
|
+0.8%
|
+0.4%
|
+0.7%
|
-0.1%
|
|
MA
|
Financial Services |
Piper Sandler |
Maintains
|
Underweight
→
Underweight
|
—
|
$448.7B
|
$319.26
|
-0.1%
|
+0.3%
|
+1.2%
|
-0.3%
|
+0.3%
|
-0.4%
|
|
NFLX
|
Communication Services |
Barclays |
Maintains
|
Equal Weight
→
Equal Weight
|
—
|
$385.7B
|
$18.59
|
-0.4%
|
-1.0%
|
+2.8%
|
-1.2%
|
-5.2%
|
-1.6%
|
|
BABA
|
Consumer Cyclical |
Benchmark |
Maintains
|
Buy
→
Buy
|
—
|
$324.7B
|
$120.13
|
-1.0%
|
-0.8%
|
+2.7%
|
-1.2%
|
-9.4%
|
-0.3%
|
|
TXN
|
Technology |
Susquehanna |
Maintains
|
Positive
→
Positive
|
—
|
$276.0B
|
$149.10
|
+0.6%
|
+1.1%
|
+2.6%
|
+0.5%
|
-1.3%
|
+0.6%
|
|
AXP
|
Financial Services |
Piper Sandler |
Maintains
|
Overweight
→
Overweight
|
—
|
$215.6B
|
$139.65
|
-0.3%
|
-1.1%
|
+2.1%
|
+0.5%
|
-0.8%
|
-1.0%
|
|
SAP
|
Technology |
Barclays |
Downgrade
|
Overweight
→
Equal Weight
|
—
|
$210.1B
|
$89.16
|
+1.0%
|
+0.8%
|
+0.9%
|
-0.1%
|
-2.5%
|
-2.2%
|
|
PEP
|
Consumer Defensive |
Barclays |
Maintains
|
Overweight
→
Overweight
|
—
|
$206.5B
|
$169.01
|
+0.6%
|
+1.0%
|
-0.2%
|
+0.9%
|
-0.8%
|
-0.6%
|
|
PEP
|
Consumer Defensive |
JP Morgan |
Maintains
|
Overweight
→
Overweight
|
—
|
$206.5B
|
$169.01
|
+0.6%
|
+1.0%
|
-0.2%
|
+0.9%
|
-0.8%
|
-0.6%
|
|
DIS
|
Communication Services |
Vertical Research |
Downgrade
|
Positive
→
Perform
|
—
|
$185.2B
|
$97.18
|
+0.4%
|
-1.1%
|
+1.4%
|
-1.6%
|
-2.3%
|
-0.0%
|
|
UNP
|
Industrials |
Citigroup |
Maintains
|
Neutral
→
Neutral
|
—
|
$161.2B
|
$210.17
|
-0.3%
|
-0.2%
|
+1.4%
|
-1.4%
|
+0.1%
|
-1.6%
|
|
UNP
|
Industrials |
Susquehanna |
Downgrade
|
Positive
→
Neutral
|
—
|
$161.2B
|
$210.17
|
-0.3%
|
-0.2%
|
+1.4%
|
-1.4%
|
+0.1%
|
-1.6%
|
|
ABT
|
Healthcare |
Wolfe Research |
Maintains
|
Underperform
→
Underperform
|
—
|
$154.4B
|
$109.30
|
-0.4%
|
-0.6%
|
+0.7%
|
-0.2%
|
-0.3%
|
-0.5%
|
|
CME
|
Financial Services |
UBS |
Maintains
|
Buy
→
Buy
|
—
|
$108.9B
|
$204.36
|
+0.7%
|
-0.2%
|
+2.4%
|
+0.1%
|
-0.3%
|
-2.5%
|
|
CME
|
Financial Services |
Raymond James |
Maintains
|
Outperform
→
Outperform
|
—
|
$108.9B
|
$204.36
|
+0.7%
|
-0.2%
|
+2.4%
|
+0.1%
|
-0.3%
|
-2.5%
|
|
CME
|
Financial Services |
Credit Suisse |
Maintains
|
Neutral
→
Neutral
|
—
|
$108.9B
|
$204.36
|
+0.7%
|
-0.2%
|
+2.4%
|
+0.1%
|
-0.3%
|
-2.5%
|
|
MDT
|
Healthcare |
Wolfe Research |
Maintains
|
Underperform
→
Underperform
|
—
|
$101.4B
|
$90.49
|
-0.5%
|
-1.0%
|
-0.1%
|
-0.0%
|
-0.6%
|
-0.3%
|
|
BK
|
Financial Services |
Morgan Stanley |
Maintains
|
Equal Weight
→
Equal Weight
|
—
|
$96.7B
|
$42.08
|
-0.8%
|
-1.2%
|
+1.7%
|
-0.9%
|
-0.4%
|
+0.1%
|
|
HCA
|
Healthcare |
BMO Capital |
Downgrade
|
Market Perform
→
Underperform
|
—
|
$93.4B
|
$172.58
|
-2.5%
|
-3.8%
|
+5.2%
|
-1.2%
|
-1.9%
|
+0.4%
|